
Suzanne Marie Noakes
Examiner (ID: 17824)
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656, 1653 |
| Total Applications | 1691 |
| Issued Applications | 1090 |
| Pending Applications | 193 |
| Abandoned Applications | 452 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16718614
[patent_doc_number] => 20210085761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => Compositions and Methods for Treating Celiac Sprue Disease
[patent_app_type] => utility
[patent_app_number] => 17/114294
[patent_app_country] => US
[patent_app_date] => 2020-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12728
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17114294
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/114294 | Compositions and Methods for Treating Celiac Sprue Disease | Dec 6, 2020 | Abandoned |
Array
(
[id] => 18184559
[patent_doc_number] => 20230045289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => CLEANING COMPOSITIONS COMPRISING DISPERSINS IX
[patent_app_type] => utility
[patent_app_number] => 17/786557
[patent_app_country] => US
[patent_app_date] => 2020-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41140
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786557
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/786557 | CLEANING COMPOSITIONS COMPRISING DISPERSINS IX | Dec 6, 2020 | Pending |
Array
(
[id] => 18195027
[patent_doc_number] => 20230048546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => CLEANING COMPOSITIONS COMPRISING DISPERSINS VI
[patent_app_type] => utility
[patent_app_number] => 17/786562
[patent_app_country] => US
[patent_app_date] => 2020-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72329
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786562
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/786562 | CLEANING COMPOSITIONS COMPRISING DISPERSINS VI | Dec 6, 2020 | Pending |
Array
(
[id] => 18195027
[patent_doc_number] => 20230048546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => CLEANING COMPOSITIONS COMPRISING DISPERSINS VI
[patent_app_type] => utility
[patent_app_number] => 17/786562
[patent_app_country] => US
[patent_app_date] => 2020-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72329
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786562
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/786562 | CLEANING COMPOSITIONS COMPRISING DISPERSINS VI | Dec 6, 2020 | Pending |
Array
(
[id] => 16839499
[patent_doc_number] => 20210147511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => THERAPEUTIC VARIANT ALPHA-2-MACROGLOBULIN COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/110766
[patent_app_country] => US
[patent_app_date] => 2020-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17110766
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/110766 | Therapeutic variant alpha-2-macroglobulin compositions | Dec 2, 2020 | Issued |
Array
(
[id] => 18529928
[patent_doc_number] => 20230234995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => CHO CELL-DERIVED PROTEIN SECRETORY FACTORS AND EXPRESSION VECTORS COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/781873
[patent_app_country] => US
[patent_app_date] => 2020-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9238
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781873
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/781873 | CHO CELL-DERIVED PROTEIN SECRETORY FACTORS AND EXPRESSION VECTORS COMPRISING THE SAME | Nov 30, 2020 | Pending |
Array
(
[id] => 16824269
[patent_doc_number] => 20210139562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => REMOVAL OF SERINE PROTEASES BY TREATMENT WITH FINELY DIVIDED SILICON DIOXIDE
[patent_app_type] => utility
[patent_app_number] => 17/103618
[patent_app_country] => US
[patent_app_date] => 2020-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65685
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17103618
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/103618 | Removal of serine proteases by treatment with finely divided silicon dioxide | Nov 23, 2020 | Issued |
Array
(
[id] => 18932293
[patent_doc_number] => 11884700
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Methods of inactivating viral contaminants
[patent_app_type] => utility
[patent_app_number] => 17/100236
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 30
[patent_no_of_words] => 27827
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17100236
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/100236 | Methods of inactivating viral contaminants | Nov 19, 2020 | Issued |
Array
(
[id] => 16673407
[patent_doc_number] => 20210062170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => SITE-SPECIFIC ENZYMES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/098974
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34075
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098974
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/098974 | SITE-SPECIFIC ENZYMES AND METHODS OF USE | Nov 15, 2020 | Abandoned |
Array
(
[id] => 16898983
[patent_doc_number] => 20210177899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => GENOME EDITING OF GRAFT-DERIVED T-CELLS FOR POST-TRANSPLANT IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/098258
[patent_app_country] => US
[patent_app_date] => 2020-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18995
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098258
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/098258 | Genome editing of graft-derived T-cells for post-transplant immunotherapy | Nov 12, 2020 | Issued |
Array
(
[id] => 18036543
[patent_doc_number] => 20220380758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => TYPE I-B CRISPR-ASSOCIATED TRANSPOSASE SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 17/773104
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 104227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -79
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17773104
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/773104 | TYPE I-B CRISPR-ASSOCIATED TRANSPOSASE SYSTEMS | Oct 29, 2020 | Pending |
Array
(
[id] => 16613957
[patent_doc_number] => 20210032610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => Compositions for Treating Ectopic Calcification Disorders, and Methods Using Same
[patent_app_type] => utility
[patent_app_number] => 17/075398
[patent_app_country] => US
[patent_app_date] => 2020-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19911
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17075398
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/075398 | Compositions for Treating Ectopic Calcification Disorders, and Methods Using Same | Oct 19, 2020 | Abandoned |
Array
(
[id] => 16614023
[patent_doc_number] => 20210032676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => SYNTHETIC OPLOPHORUS LUCIFERASES WITH ENHANCED LIGHT OUTPUT
[patent_app_type] => utility
[patent_app_number] => 17/075415
[patent_app_country] => US
[patent_app_date] => 2020-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15883
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17075415
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/075415 | Synthetic oplophorus luciferases with enhanced light output | Oct 19, 2020 | Issued |
Array
(
[id] => 18058388
[patent_doc_number] => 20220389474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => MICROBIAL HOST CELLS FOR THE PRODUCTION OF HETEROLOGOUS CYANURIC ACID HYDROLASES AND BIURET HYDROLASES
[patent_app_type] => utility
[patent_app_number] => 17/770269
[patent_app_country] => US
[patent_app_date] => 2020-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19431
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17770269
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/770269 | MICROBIAL HOST CELLS FOR THE PRODUCTION OF HETEROLOGOUS CYANURIC ACID HYDROLASES AND BIURET HYDROLASES | Oct 13, 2020 | Pending |
Array
(
[id] => 16791720
[patent_doc_number] => 20210121537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => Methods and Compositions for Treating Phenylketonuria
[patent_app_type] => utility
[patent_app_number] => 17/064332
[patent_app_country] => US
[patent_app_date] => 2020-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14468
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17064332
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/064332 | Methods and Compositions for Treating Phenylketonuria | Oct 5, 2020 | Abandoned |
Array
(
[id] => 18452015
[patent_doc_number] => 20230193294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => mRNA and Method for Producing Same, Device for Producing Protein, and Method for Producing Protein
[patent_app_type] => utility
[patent_app_number] => 17/768942
[patent_app_country] => US
[patent_app_date] => 2020-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17768942
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/768942 | mRNA and Method for Producing Same, Device for Producing Protein, and Method for Producing Protein | Oct 4, 2020 | Pending |
Array
(
[id] => 18452015
[patent_doc_number] => 20230193294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => mRNA and Method for Producing Same, Device for Producing Protein, and Method for Producing Protein
[patent_app_type] => utility
[patent_app_number] => 17/768942
[patent_app_country] => US
[patent_app_date] => 2020-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17768942
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/768942 | mRNA and Method for Producing Same, Device for Producing Protein, and Method for Producing Protein | Oct 4, 2020 | Pending |
Array
(
[id] => 18452015
[patent_doc_number] => 20230193294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => mRNA and Method for Producing Same, Device for Producing Protein, and Method for Producing Protein
[patent_app_type] => utility
[patent_app_number] => 17/768942
[patent_app_country] => US
[patent_app_date] => 2020-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17768942
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/768942 | mRNA and Method for Producing Same, Device for Producing Protein, and Method for Producing Protein | Oct 4, 2020 | Pending |
Array
(
[id] => 18452015
[patent_doc_number] => 20230193294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => mRNA and Method for Producing Same, Device for Producing Protein, and Method for Producing Protein
[patent_app_type] => utility
[patent_app_number] => 17/768942
[patent_app_country] => US
[patent_app_date] => 2020-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17768942
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/768942 | mRNA and Method for Producing Same, Device for Producing Protein, and Method for Producing Protein | Oct 4, 2020 | Pending |
Array
(
[id] => 16583163
[patent_doc_number] => 20210017565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => PROCESS FOR MANIPULATING THE LEVEL OF GLYCAN CONTENT OF A GLYCOPROTEIN
[patent_app_type] => utility
[patent_app_number] => 17/062199
[patent_app_country] => US
[patent_app_date] => 2020-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17062199
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/062199 | PROCESS FOR MANIPULATING THE LEVEL OF GLYCAN CONTENT OF A GLYCOPROTEIN | Oct 1, 2020 | Abandoned |